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INTRODUCTION
Risk stratification is important in patients with acute 
pulmonary embolism (PE) because optimal management, 
monitoring, and therapeutic strategies depend on the 
prognosis (1, 2). Many computed tomography (CT) 
Prognostic Value of Dual-Energy CT-Based Iodine 
Quantification versus Conventional CT in Acute 
Pulmonary Embolism: A Propensity-Match Analysis
Dong Jin Im, MD, Jin Hur, MD, PhD, Kyunghwa Han, PhD, Young Joo Suh, MD, PhD,  
Yoo Jin Hong, MD, PhD, Hye-Jeong Lee, MD, PhD, Young Jin Kim, MD, PhD, Byoung Wook Choi, MD, PhD
All authors: Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 
Seoul, Korea
Objective: The present study aimed to investigate whether quantitative dual-energy computed tomography (DECT) parameters 
offer an incremental risk stratification benefit over the CT ventricular diameter ratio in patients with acute pulmonary embolism 
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parameters have been proposed as potential predictors of PE 
severity and clinical outcome. Currently, the CT ventricular 
diameter (VD) ratio is a well-established and widely used 
prognostic indicator in patients with acute PE. A previous 
meta-analysis demonstrated that the quantitative CT 
parameter of right to left ventricle diameter ratio greater 
than 1 showed the strongest predictive ability and most 
robust evidence for an adverse clinical outcome in patients 
with acute PE (3). 
Dual-energy computed tomography (DECT) has been 
used in the diagnosis and evaluation of PE, and recent 
studies have shown that quantitative parameters of DECT 
are helpful in predicting the clinical outcome of patients 
with PE (4-13). A previous study demonstrated that DECT 
perfusion imaging could display pulmonary perfusion 
defects with good agreement to scintigraphic findings (5). 
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Several studies have described the functional relevance of 
perfusion defects (PDs) detected on DECT, and studies have 
shown that the extent of PDs measured with DECT correlates 
with an adverse clinical outcome in patients with PE (9, 
10). Studies demonstrating the clinical utility of PDs using 
DECT have been published, but there is little evidence for 
the additional risk stratification benefit of the CT VD ratio 
in patients with acute PE (8-11).
The purpose of the present study was to investigate 
whether quantitative DECT parameters offer incremental risk 
stratification benefits over the CT VD ratio in patients with 
acute PE by using a propensity score analysis. 
MATERIALS AND METHODS
Patient Population
This single-center, propensity score-matched study 
compared the predictive value of quantitative DECT 
parameters and CT VD ratio in patients with acute PE. 
Institutional Review Board approval was obtained, and 
the requirement for informed consent was waived for this 
retrospective propensity score-matched study. 
All consecutive patients who underwent CT pulmonary 
angiography (CTPA) or DECT pulmonary angiography (DE CT-
PA) and were suspected to have acute PE between January 
2015 and December 2017 were considered potentially 
eligible for this analysis. Among 3419 patients (CTPA group, 
n = 2045, DECT group, n = 1374), the following patients 
were excluded: patients with negative CT results (n = 
2486), patients who did not clinically or radiologically meet 
the criteria for acute PE (n = 47), those in whom DECT or CT 
was performed as a follow-up CT examination after receiving 
anticoagulation therapy (n = 105), and those for whom CT 
image quality was insufficient or CT image data were not 
available (n = 21). Finally, 484 patients (23.6%) who were 
diagnosed with acute PE by CTPA and 276 patients (20.1%) 
who were diagnosed with acute PE by DECT were recruited 
for the present study (Fig. 1).
Patient clinical information, including age, sex, and 
medical history (hypertension, diabetes mellitus, smoking, 
heart disease [including congenital heart disease, coronary 
artery disease, myocardial infarction, valvular heart disease, 
heart failure, arrhythmia and cardiomyopathy], chronic 
obstructive pulmonary disease [COPD], pneumonia, history 
of cancer, history of deep vein thrombosis [DVT]), was 
recorded based on patient medical records. 
To reduce potential selection bias related to the use 
of a non-randomized cohort to generate two groups 
(CTPA and DECT groups) with comparable characteristics, 
propensity score–matched analyses were performed (14). 
The following variables were used to develop the propensity 
score and create a well-matched control group: age, sex, 
hypertension, diabetes mellitus, smoking, heart disease, 
COPD, pneumonia, history of cancer, and history of DVT. 
The balance of covariates between the groups was assessed 
by the absolute standardized mean difference before and 
after the matching procedure. An absolute standardized 
mean difference of 0.1 or less indicates balanced covariates 
between the two groups (15).
The propensity-matched study population included 240 
patients with acute PE in the CTPA group and 240 patients 
with acute PE in the DECT group. Altogether, 260 (54.1%) 
were men, and the mean age was 64.9 years (64.9 ± 13.5).
CT Examination
CTPA was performed for all participants by using a 64- 
or 128-channel CT system (Revolution EVO, GE Healthcare, 
Chicago, IL, USA or Somatom Definition AS, Siemens 
Healthineers, Forchheim, Germany), and DE CT-PA was 
performed for all participants by using a dual-source CT 
system (Somatom Definition Flash, Siemens Healthineers). 
All patients received 50–90 mL of iopamidol (370 mg/
mL iodine, Pamiray 370, Dongkook Pharmaceutical, Seoul, 
Korea) via an antecubital vein at 4 mL/s by a power 
Patients with CTPA or DE CT-PA
(n = 3419)
Study cohort (n = 760)
Acute PE with CTPA
(n = 484)
Acute PE with CTPA
(n = 240)
Acute PE with DECT
(n = 276)




  - Negative results (n = 2486)
  - No acute PE criteria (n = 47)
  - CT after receiving anticoagulation
    therapy (n = 105)
  - Inadequate CT image data (n = 21)
Fig. 1. Flowchart of patient selection. CTPA = CT pulmonary 
angiography, DECT = dual-energy CT, DE CT-PA = DECT pulmonary 
angiography, PE = pulmonary embolism
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injector. Following contrast injection, 30 mL of saline was 
administered. During the scan, patients held their breath on 
inspiration. Pulmonary trunk attenuation was tracked by a 
bolus-tracking technique. Image acquisition was triggered 
manually once attenuation in the pulmonary trunk reached 
100 Hounsfield units (HU). Radiation exposure was estimated 
from the dose-length product (DLP). The calculated mean 
radiation dose was 5.2 mSv (DLP range, 189–903 mGy*cm) 
based on the scan range and patient body weight.
Image Analysis
A radiologist with over 10 years of experience in chest CT 
analysis analyzed the CT data; the radiologist was blinded 
to patient identities and clinical histories. All scans were 
processed and read using a dedicated workstation equipped 
with dual-energy post-processing software (Syngo MMWP 
VE36A, Siemens Healthineers). The weighted average image 
was approximately 120 kV and was automatically generated 
from a combination of the 140-kV and 100-kV data used 
for DE CT-PA. Color-coded iodine maps were merged with 
the corresponding CT angiographic images with soft tissue 
settings to create fusion images, allowing simultaneous 
depiction of occluded PAs and lung perfusion. 
For quantitative analysis, maximal diameters of the right 
and left ventricles (RV and LV) were measured on transverse 
sections by identifying the maximal distance between the 
ventricular endocardium and the interventricular septum 
perpendicular to the long axis of the heart (Fig. 2). RV/LV 
diameter ratios were calculated by dividing the maximum 
diameters of the RV and LV. PD volume was analyzed and 
quantified from iodine maps by using dedicated Volume 
analysis software (version VE36A, Siemens Healthineers). 
PD attenuation values were measured automatically from 
-1 to -1024 HU in HU (Fig. 3). Total lung volume was 
analyzed by Lung Parenchyma Analysis (Syngo InSpace, 
Siemens Healthineers) and measured automatically by 
determining the sum of values from 1024 to 1 HU and from 
-1 to -1024 HU. The trachea and bronchus were excluded by 
a semiautomatic segmentation technique. The PDs values 
measured on iodine maps were carefully reviewed and 
compared to CT findings. PDs related to lung parenchymal 
abnormalities (e.g., infiltration, effusion, or emphysema) 
were manually excluded. The relative perfusion defect 
Fig. 2. Measurement of ventricular diameter ratio in 45-year-
old woman with acute pulmonary embolism. Axial CT image 
shows measurement of maximum diameters (black arrows) of right 
and left ventricles. Ventricular diameter is maximal distance between 
ventricular endocardium and interventricular septum perpendicular to 
long axis of heart. White arrows indicate pulmonary embolism.
Fig. 3. 68-year-old woman with acute pulmonary embolism.
A. Iodine map generated on axial CT image with dedicated software shows pulmonary embolism (arrows) and perfusion defects in both lungs. 
B. Map obtained with volume analysis software shows perfusion defect volume, measured from -1024 to -1 HU, of 261.46 cm3 and relative 





volume (RelPD%) was calculated as follows: RelPD% = PD 
volume / total lung volume x 100. To assess the inter-
observer agreement for quantitative measurements, 50 of 
240 patients in the DECT group were randomly selected and 
an independent reviewer with over 5 years of experience in 
chest CT analysis measured the PD volume and ventricular 
ratios. 
Clinical Outcome
Clinical outcome data were obtained via a review of the 
electronic medical records or by telephone contact from 
a dedicated research nurse who was blinded to the CT 
results. The primary endpoints of the present study were 
death within 30 days from any cause. Patient death status 
was ascertained by querying the National Health Insurance 
Corporation.
Statistical Analysis
An analytic sample was created using propensity score-
based matching to correct for differences in patient 
characteristics in the two groups. Propensity score matching 
was conducted in a 1:1 ratio by nearest neighbor matching. 
The adequacy of the propensity model was confirmed by 
checking the covariate balance before and after matching.
Comparisons between the CTPA and DECT groups were 
performed. The differences between categorical variables 
were analyzed by chi-squared test or Fisher’s exact test. The 
differences between continuous variables were analyzed 
by the Shapiro–Wilk test or Mann–Whitney U test. A Cox 
proportional hazards regression model was used to identify 
associations between CT parameters and outcomes and to 
identify potential predictors. Only variables with p values 
less than 0.20 in univariate analyses were added to the final 
multivariate models to prevent model over-fitting. From the 
Cox proportional hazards model, hazard ratios (HRs) and 
95% confidence intervals (CIs) were calculated. Concordance 
(C) statistics were used to compare the predictive prognosis 
between the two groups. Inter-observer agreement was 
tested using intraclass correlation coefficients (ICCs). A p 
value < 0.05 was considered statistically significant. All 
statistical analyses were performed using R (version 3.2.2., 
R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Baseline Clinical and CT Characteristics
Baseline characteristics of the two groups are shown in 
Table 1. Both groups were matched for baseline variables, 
and no significant differences were observed for any of the 
baseline comparisons. 
In the CTPA group, patients who died showed a higher 
prevalence of pneumonia and cancer (all p < 0.05). In the 
DECT group, patients who died showed a higher prevalence 
of pneumonia, cancer, and DVT (all p < 0.05). Other clinical 
characteristics were not significantly different between 
patients who survived and those who died (Table 2). 
In both groups, VD ratios (1.10 vs. 0.97; p < 0.001 
and 1.09 vs. 0.94; p < 0.001) were significantly higher in 
Table 1. Patient Clinical Characteristics before and after Propensity Score Matching
Characteristics













Age (years) 67.8 ± 15.4 64.6 ± 13.9 -0.227 64.3 ± 15.8 65.4 ± 13.5 0.079
Sex (female) 268 (55.4) 150 (54.3) -0.021 128 (52.9) 132 (54.5) 0.033
Clinical condition
Hypertension 213 (44.0) 137 (49.6) 0.112 118 (48.8) 118 (48.8) 0
Diabetes mellitus 88 (18.2) 66 (23.9) 0.134 53 (21.9) 54 (22.3) 0.009
Smoking* 117 (24.2) 57 (20.7) -0.086 55 (22.7) 53 (21.9) -0.020
Heart disease† 26 (5.4) 29 (10.5) 0.167 16 (6.6) 21 (8.7) 0.067
COPD 30 (6.2) 20 (7.2) 0.040 19 (7.9) 19 (7.9) 0
Pneumonia 63 (13.0) 38 (13.8) 0.021 33 (13.6) 33 (13.6) 0
Cancer 206 (42.6) 160 (58.0) 0.311 126 (52.1) 131 (54.1) 0.041
DVT 57 (11.8) 77 (27.9) 0.358 48 (19.8) 48 (19.8) 0
Values are presented as mean ± standard deviation or patient number with (%). *Current or former smoker, †Heart disease includes 
congenital heart disease, coronary artery disease, myocardial infarction, valvular heart disease, heart failure, arrhythmia and 
cardiomyopathy. COPD = chronic obstructive pulmonary disease, CTPA = CT pulmonary angiography, DECT = dual-energy CT, DVT = deep 
vein thrombosis
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the death group than in the survival group. In the DECT 
group, the RelPD% (10.21% vs. 7.73%; p < 0.001) was also 
significantly higher in the death group than in the survival 
group (Table 2). 
Clinical and CT Variables Associated with Outcome
During the median follow-up period of 133 days 
(interquartile range: 35–401 days), there were 35 deaths 
within 30 days from any cause in the CTPA group and 45 
deaths within 30 days from any cause in the DECT group. 
In univariate analysis using a Cox hazards regression 
model in the CTPA group, pneumonia and cancer were 
predictors of all-cause death within 30 days (all, p < 0.05) 
(Table 3). Patients with a larger VD ratio (≥ 1 vs. < 1) had a 
significantly higher risk of death within 30 days (p = 0.001) 
(Table 3). In the DECT group, univariate analysis using a 
Cox hazards regression model revealed that pneumonia, 
cancer, and DVT were predictors of all-cause death within 
30 days (all, p < 0.05). Patients with a larger VD ratio (≥ 1 
vs. < 1) and a larger PD volume had a significantly higher 
risk of death within 30 days (all p < 0.001) (Table 3).
In multivariate analysis using a Cox hazards regression 
model adjusted for age, pneumonia, cancer, and VD ratio 
(≥ 1) were associated with an increased risk of death 
within 30 days. In the CTPA group, pneumonia, cancer, 
and VD ratio (≥ 1) (HR, 3.707; 95% CI, 1.730–7.941; p 
< 0.001) were associated with an increased risk of death 
within 30 days. In the DECT group, pneumonia, cancer, VD 
ratio (≥ 1) (HR, 5.573; 95% CI, 2.758–11.261; p < 0.001) 
and RelPD% (HR, 1.038; 95% CI, 1.005–1.072; p = 0.022) 
were associated with an increased risk of death within 30 
days. The C-statistics showed no statistically significant 
difference between the CTPA and DECT groups for predicting 
death within 30 days (C-statistics: 0.759 vs. 0.819, p = 
0.117) (Table 4). 
There was excellent inter-observer agreement between 
the two radiologists in the measurement parameters of 
DECT. The ICCs for RelPD% and VD ratios were 0.88 (95% CI: 
0.81–0.97) and 0.93 (95% CI: 0.89–0.99), respectively.
DISCUSSION
This study was designed to investigate whether 
quantitative DECT parameters provide incremental risk 
Table 2. Baseline Characteristics of Matched Study Population according to Mortality Status
Characteristics
CTPA Group DECT Group 
Survivor (n = 207) Death (n = 35) P Survivor (n = 197) Death (n = 45) P
Age (years) 65 (58, 78) 67 (55, 75) 0.115 69 (57, 74) 70 (62, 74) 0.148
Sex (female) 107 (51.7) 21 (60.0) 0.362 111 (56.3) 21 (46.7) 0.239
Clinical condition
Hypertension 98 (47.3) 20 (57.1) 0.283 91 (46.2) 27 (60.0) 0.094
Diabetes mellitus 44 (21.3) 9 (25.7) 0.555 42 (21.3) 12 (26.7) 0.437
Smoking* 47 (22.7) 8 (22.9) 0.984 42 (21.3) 11 (24.4) 0.647
Heart disease† 13 (6.3) 3 (8.6) 0.613 17 (8.6) 4 (8.9) 0.956
COPD 14 (6.8) 5 (14.3) 0.126 13 (6.6) 6 (13.3) 0.129
Pneumonia 24 (11.6) 9 (25.7) 0.024 18 (9.1) 15 (33.3) < 0.001
Cancer 99 (47.8) 27 (77.1) 0.001 96 (48.7) 35 (77.8) 0.001
DVT 44 (21.3) 4 (11.4) 0.175 45 (22.8) 3 (6.7) 0.014
Treatment
Anticoagulants 177 (85.5) 26 (74.2) 0.150 159 (80.7) 33 (73.3) 0.367
Thrombolytic treatment 6 (2.8) 2 (5.7) 0.703 5 (2.5) 2 (4.4) 0.845
Inferior vena cava filter 22 (10.6) 0 0.088 23 (11.6) 1 (2.2) 0.102
CT measurement
Ventricular diameter ratio, median 0.97 (0.87, 1.26) 1.10 (0.98, 1.24) < 0.001 0.94 (0.87, 1.01) 1.09 (0.99, 1.32) < 0.001
Ventricular diameter ratio (≥ 1) 89 (43.0) 26 (74.3) < 0.001 53 (26.9) 33 (73.3) < 0.001
Relative perfusion defect 







Values are presented as median value (1st quantile, 3rd quantile) or patient number (%). *Current or former smoker, †Heart disease 





stratification benefits over the CT VD ratio in patients with 
acute PE by using a propensity score analysis. Based on this 
study, quantitative measurement of lung PD volume by DECT 
offered no added benefit over CT VD ratio for predicting all-
cause death within 30 days. 
Risk stratification for patients with acute PE is important 
to establish appropriate treatment and management. CT 
parameters have emerged as prognostic markers to assess 
the severity of hemodynamic compromise from acute 
PE and identify patients at heightened risk for fatal or 
nonfatal adverse events, thus guiding clinical management 
(3, 16, 17). For clinical purposes, the RV/LV diameter 
ratio measured on CT shows the strongest predictive value 
across all endpoints and provides the most robust evidence 
for adverse clinical outcomes in patients with acute PE. 
Many studies have supported that RV dysfunction assessed 
on CT was associated with an increased risk of early 
complications, including all-cause death and PE-related 
serious adverse events (16-22). In addition, previous meta-
analyses have demonstrated that increased RV/LV diameter 
ratio is the strongest predictor of adverse clinical outcomes 
in patients with acute PE (3, 21, 22). This measurement 
is a simple quantitative value that can be easily measured 
in axial or 4-chamber images using CT. Our results are in 
agreement with those of previous studies. In our study, 
right ventricular dysfunction was assessed by CT by using 
two-dimensional axial transverse images. According to 
our study, right ventricular dysfunction on CT was an 
independent predictor of all-cause death within 30 days. 
DECT has been proposed as a new imaging technique 
Table 3. Univariate Analysis Using Cox Proportional Hazards Regression Model
Characteristics
CTPA Group DECT Group
HR 95% CI P HR 95% CI P
Age 1.009 0.987–1.032 0.417 1.024 0.998–1.049 0.065 
Sex (female) 1.317 0.670–2.590 0.424 0.672 0.374–1.207 0.283 
Hypertension 1.442 0.738–2.817 0.283 1.616 0.890–2.934 0.115 
Diabetes mellitus 1.277 0.598–2.726 0.526 1.289 0.666–2.496 0.451 
Smoking* 0.992 0.451–2.183 0.983 1.180 0.598–2.330 0.632 
Heart disease† 1.387 0.425–4.531 0.587 1.256 0.450–3.510 0.663 
COPD 2.082 0.807–5.366 0.129 2.177 0.921–5.144 0.076 
Pneumonia 2.554 1.196–5.451 0.015 3.949 2.120–7.357 < 0.001
Cancer 3.329 1.512–7.329 0.002 3.413 1.689–6.895 < 0.001
DVT 0.502 0.177–1.423 0.195 0.260 0.081–0.840 0.024 
Anticoagulants 1.787 0.774–4.072 0.278 2.104 0.813–5.062 0.181
Thrombolytic treatment 0.518 0.321–0.947 0.186 0.584 0.238–1.142 0.238
Inferior vena cava filter 2.031 0.781–9.712 0.142 2.579 0.744–10.164 0.115
VD ratio (≥ 1) 3.407 1.596–7.270 0.001 7.471 3.593–15.534 < 0.001
RelPD% - - - 1.065 1.013–1.120 0.012 
*Current or former smoker, †Heart disease includes congenital heart disease, coronary artery disease, myocardial infarction, valvular heart 
disease, heart failure, arrhythmia and cardiomyopathy. Dash (-) indicates no patient. CI = confidence interval, HR = hazard ratio, RelPD% 
= relative perfusion defect volume, VD = ventricular diameter
Table 4. Multivariate Analysis Using Cox Proportional Hazards Regression Model
Characteristics
CTPA Group DECT Group
HR 95% CI P HR 95% CI P
Age 1.002 0.961–1.024 0.817 1.032 1.004–1.065 0.260 
COPD 2.064 0.793–5.370 0.137 1.578 0.624–3.908 0.342
Pneumonia 2.092 0.971–4.509 0.049 2.178 1.102–4.288 0.025 
Cancer 3.111 1.380–7.013 0.006 3.972 1.936–8.147 < 0.001 
DVT 0.739 0.255–2.141 0.577 0.513 0.153–1.718 0.282 
VD ratio (≥ 1 vs. < 1) 3.707 1.730–7.941 < 0.001 5.573 2.758–11.261 < 0.001
RelPD% - - - 1.038 1.005–1.072 0.022
Concordance-index 0.759 0.819
Dash (-) indicates no patient. 
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for detecting PE (11, 12). A unique feature of DECT is 
that it allows differentiation of materials based on their 
energy absorption (4, 23). Thus, DECT allows simultaneous 
assessment of pulmonary vasculature and parenchymal 
iodine distribution (5, 6, 24). In the lung, the pattern of 
iodine enhancement on DECT has been shown to correspond 
to lung blood volume on planar scintigraphy (5). Several 
studies have reported that the quantitative values of lung 
PDs on DECT correlated with right ventricular dysfunction 
and adverse clinical outcomes (8-11). A previous study 
reported that the extent of lung PDs on DECT correlated 
well with right ventricular dysfunction on CT and death 
(9). Another study demonstrated that of all evaluated CT 
parameters, the PD volume measured by DECT showed the 
highest predictive power for detecting an adverse clinical 
outcome (10). Conversely, our previous study revealed 
that lung PDs quantified on DECT had no added benefit in 
predicting death within 30 days or for predicting PE-related 
death (11). Based on previous studies, quantitative DECT 
parameters have potential for use as prognostic makers 
in acute PE. However, the value of quantitative DECT 
parameters for prognosis and risk stratification in acute 
PE is controversial. The heterogeneity of study groups, 
definitions, and outcomes prohibits consensus on the 
prognostic performance of DECT. 
We conducted a propensity score-matched study 
to compare the predictive value of quantitative DECT 
parameters and CT VD ratio in patients with acute PE. 
Propensity score adjustment is a method of balancing the 
distribution of biases and confounders between groups, 
thereby increasing between-group comparability. Propensity 
score analysis is increasingly being applied as a statistical 
method in observational studies (14). We constructed two 
models to evaluate the added value of DECT parameters (lung 
PD volume) in predicting all-cause death within 30 days. 
Although PDs measured on DECT were associated with an 
increased risk of death within 30 days, C-statistics showed 
no statistically significant difference between the two 
groups (CTPA group and DECT group) in predictive prognosis 
with respect to predicting death in patients with acute PE. 
These results suggest that DECT parameters (lung PD) had 
no added benefit over the simple quantified CT value of VD 
ratio for predicting death within 30 days in patients with 
acute PE. 
Lung perfusion imaging is based on quantification of 
tissue enhancement at serial time points following contrast 
administration. Previous studies have demonstrated that 
the extent of PDs, identified by perfusion scintigraphy, 
correlated with clinical outcomes in patients with PE (25, 
26). Consequently, the extent of PDs quantified on DECT 
is potentially predictive of hemodynamic changes in acute 
PE. Thus, these are emerging as imaging biomarkers for risk 
stratification. However, there are several issues regarding 
quantitative measurements in DECT. First, DECT scans are 
usually obtained at a single time-point, so DECT provides 
an iodine distribution map of the lung microcirculation 
at a given time point (27). Therefore, quantitative DECT 
parameters can vary according to different clinical settings 
and with different imaging protocols. Second, there is no 
standardized analytical method for lung PDs using DECT in 
terms of HU threshold and analytical software. In addition, 
additional time is required to analyze lung perfusion using 
special software. 
Our study has certain limitations. First, this study was 
conducted at a single center with a modest sample size. 
In addition, the retrospective nature of this study may be 
associated with a selection bias. However, we conducted a 
propensity score-matched study to balance the distribution 
of biases and confounders between groups. Second, the 
imaging protocol and analytical method for lung perfusion 
may have significantly influenced the results. Currently, 
there is no standardized analytical method for assessing 
lung PDs using DECT in terms of HU threshold and analytical 
software. 
In conclusion, an increased RV/LV diameter ratio was 
associated with increased risk of all-cause death within 
30 days in patients with acute PE. However, quantitative 
measurement of lung PD volume by DECT offered no added 
benefit over CT VD ratio in predicting all-cause death within 
30 days. Our present data failed to provide an additional 
benefit of functional lung assessment on DECT for predicting 
future death in patients with PE. Future large trials 
with much longer follow-up periods must be performed 
to estimate the potential influence of DECT findings on 
treatment strategies and optimize the management and 
outcome of patients with acute PE.
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